An Engineered Medium-Chain Fatty Acid Analogue Protects against Lipopolysaccharide-Induced Liver Injury in a Murine Model of Intestinal Failure-Associated Liver Disease

被引:0
|
作者
Wang, Sarah Z. [1 ]
Hirsch, Thomas I. [1 ]
Fligor, Scott C. [1 ]
Tsikis, Savas T. [1 ]
Pan, Amy [1 ]
Quigley, Mikayla [1 ]
Devietro, Angela [1 ]
Gura, Kathleen M. [1 ]
Mitchell, Paul D. [1 ]
Puder, Mark [1 ]
机构
[1] Boston Childrens Hosp, Boston, MA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S343 / S344
页数:2
相关论文
共 50 条
  • [1] A Medium-Chain Fatty Acid Analogue Prevents Intestinal Failure-Associated Liver Disease in Preterm Yorkshire Piglets
    Fligor, Scott C.
    Tsikis, Savas T.
    Hirsch, Thomas I.
    Pan, Amy
    Moskowitzova, Kamila
    Rincon-Cruz, Lorena
    Whitlock, Ashlyn E.
    Mitchell, Paul D.
    Nedder, Arthur P.
    Gura, Kathleen M.
    Fraser, David A.
    Puder, Mark
    GASTROENTEROLOGY, 2023, 165 (03) : 733 - 745.e9
  • [2] A medium-chain fatty acid analogue prevents endotoxin liver injury in a murine model
    Sarah Z. Wang
    Thomas I. Hirsch
    Scott C. Fligor
    Savas T. Tsikis
    Amy Pan
    Mikayla Quigley
    Paul D. Mitchell
    Kathleen M. Gura
    David A. Fraser
    Mark Puder
    Scientific Reports, 15 (1)
  • [3] Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation
    Xiong, Xi
    Ren, Yuqian
    Cui, Yun
    Li, Rui
    Wang, Chunxia
    Zhang, Yucai
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 96 : 1292 - 1298
  • [4] Characterization of Fatty Acid Profiles in Infants With Intestinal Failure-Associated Liver Disease
    Baker, Meredith A.
    Mitchell, Paul D.
    O'Loughlin, Alison A.
    Potemkin, Alexis K.
    Anez-Bustillos, Lorenzo
    Dao, Duy T.
    Fell, Gillian L.
    Gura, Kathleen M.
    Puder, Mark
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2018, 42 (01) : 71 - 77
  • [5] Hepcidin protects against lipopolysaccharide-induced liver injury in a mouse model of obstructive jaundice
    Huang, Ying-Hsien
    Yang, Ya-Ling
    Tiao, Mao-Meng
    Kuo, Ho-Chang
    Huang, Li-Tung
    Chuang, Jiin-Haur
    PEPTIDES, 2012, 35 (02) : 212 - 217
  • [6] Essential Fatty Acid Deficiency with SMOFlipid Reduction in an Infant with Intestinal Failure-Associated Liver Disease
    Memon, Naureen
    Hussein, Karen
    Hegyi, Thomas
    Herdt, Aimee
    Griffin, Ian J.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2019, 43 (03) : 438 - 441
  • [7] Intestinal failure-associated liver disease model: a reduced phytosterol intravenous lipid emulsion prevents liver injury
    Fligor, Scott C.
    Hirsch, Thomas I.
    Tsikis, Savas T.
    Pan, Amy
    Quigley, Mikayla
    Gura, Kathleen M.
    Puder, Mark
    PEDIATRIC RESEARCH, 2024,
  • [8] Intestinal Failure-Associated Liver Disease and Eicosapentaenoic Acid/Arachidonic Acid Ratio
    Wataru Miura
    Nobuhiko Nagano
    Ryota Kato
    Aya Okahashi
    Kayo Yoshikawa
    Kensuke Ohashi
    Tsugumichi Koshinaga
    Ichiro Morioka
    The Indian Journal of Pediatrics, 2019, 86 : 548 - 550
  • [9] Intestinal Failure-Associated Liver Disease and Eicosapentaenoic Acid/Arachidonic Acid Ratio
    Miura, Wataru
    Nagano, Nobuhiko
    Kato, Ryota
    Okahashi, Aya
    Yoshikawa, Kayo
    Ohashi, Kensuke
    Koshinaga, Tsugumichi
    Morioka, Ichiro
    INDIAN JOURNAL OF PEDIATRICS, 2019, 86 (06): : 548 - 550
  • [10] A STRUCTURALLY ENGINEERED FATTY ACID (SEFA-6179) PREVENTS CHOLESTASIS, STEATOSIS, AND FIBROSIS IN A PRETERM PIGLET MODEL OF INTESTINAL FAILURE-ASSOCIATED LIVER DISEASE
    Fligor, Scott C.
    Tsikis, Savas
    Hirsch, Thomas
    Pan, Amy
    Mitchell, Paul
    Moskowitzova, Kamila
    Rincon-Cruz, Lorena
    Whitlock, Ashlyn
    Nedder, Arthur
    Gura, Kathleen M.
    Puder, Mark
    GASTROENTEROLOGY, 2022, 162 (07) : S1389 - S1389